Acute myocarditis following administration of BNT162b2 vaccine

Abstract

The wide use of vaccines was linked with rare but serious complications in adults, causing a global concern. Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 vaccine.

Keywords

• COVID-19
• SARS-COV-2
• Myocarditis
• BNT162b2
• Pfizer-BioNTech
• Vaccine